Psychedelic Lobbying and Regulatory Capture
Bill of Health
MARCH 4, 2024
By Vincent Joralemon Psychedelic companies and advocacy groups are spending substantial resources to influence regulatory policy, shaping what the blossoming field will ultimately cohere into. When that leads to undue influence, the result is known as “regulatory capture.” What is Regulatory Capture?
Let's personalize your content